Pandemic Risk Management for the Maritime Industry Testing

# Pandemic Risk Management for the Maritime Industry Testing

Pandemic risk management for the maritime industry uses a structured testing chain covering crew, passengers, and the vessel environment. Test objects include respiratory specimens, surface swabs, and onboard air samples. This article explains scope, specimen collection, RT-PCR and rapid antigen screening, environmental monitoring, assay performance, and onboard protocols with outbreak response criteria.

Scope and objects

The scope of maritime pandemic testing runs from individual diagnostic screening to environmental verification of vessel hygiene. The primary objects are biological specimens from crew and passengers. These are mainly nasopharyngeal or oropharyngeal swabs and saliva. Environmental samples come from high-touch surfaces and recirculated air. Testing divides into three layers: pre-embarkation screening, surveillance during voyages, and reactive testing after a suspected case. Each layer carries distinct decision thresholds. So the scope statement should record who is tested, at what interval, and by which method. Environmental objects include handrails, door handles, galley surfaces, shared consoles, and air handling units. A written scope document lets the master and designated medical officer apply consistent criteria across ports and crew changes. It also defines the records kept for port health authorities and occupational health files.

Sample types and onboard collection

Specimen quality determines whether molecular results can be interpreted. Collection procedure therefore needs strict control. Upper respiratory swabs remain the main sample. The swab is inserted along the nasal floor to the nasopharynx, rotated against the mucosa for several seconds, and placed into sterile transport medium. Oropharyngeal swabs sample the tonsillar pillars and posterior pharyngeal wall. Dual swabbing increases viral load recovery. Saliva is an acceptable alternative when swab collection is impractical. It must go into a leak-proof container without food residue. Collection staff should wear gloves, eye protection, and a fitted mask. Label each tube with identity, date, time, and sampling site. Keep specimens refrigerated during holding and transport, using qualified cold-chain packaging and a documented temperature record. Poorly labelled, leaked, or overheated specimens must be rejected rather than tested. A false negative from a degraded sample carries serious operational consequences at sea.

Pathogen

screening by RT-PCR and rapid antigen testing
Two method families dominate onboard pathogen screening. Reverse transcription polymerase chain reaction (RT-PCR) extracts viral RNA from the specimen and converts it to complementary DNA. It then amplifies target gene regions with sequence-specific primers and fluorescent probes. Instrument software reads the amplification curve and reports a cycle threshold for each target. RT-PCR suits confirmatory diagnosis, pre-boarding clearance, and pooled surveillance screening of asymptomatic crews. Rapid antigen testing uses lateral-flow immunochromatography instead. Labelled antibodies bind viral surface proteins, and a visible control and test line appear within minutes. No laboratory instrumentation is needed. Rapid antigen kits suit point-of-care triage of symptomatic individuals and outbreak screening when immediate cohorting decisions are required. For maritime operations, a two-tier design works best: rapid antigen testing at the point of care, followed by RT-PCR confirmation for negative results that conflict with clinical suspicion or cases that trigger port reporting.

Surface

and air environmental monitoring — swab and PCR assays
Environmental monitoring verifies whether onboard infection control measures are working. It does not diagnose individuals. Surface sampling uses sterile synthetic-fibre swabs pre-moistened with transport medium. The swab is wiped over a defined template area of a high-contact surface, then analysed by PCR assays adapted for environmental samples. Interpret swab results with care. Detection of viral nucleic acid indicates genetic material is present, not necessarily infectious virus. A positive surface result should trigger recleaning and resampling, not a quarantine decision on its own. Air monitoring can use settle plates for passive deposition assessment. Active samplers draw a measured air volume through a collection substrate, with later PCR analysis of the collected material. Focus sampling on galley surfaces, mess areas, gym equipment, bridge consoles, and air return grilles. Repeat sampling after corrective cleaning shows whether the intervention worked. Paired before-and-after records form part of the vessel hygiene log.

Assay

performance: sensitivity, specificity and turnaround time
Method selection depends on how three performance dimensions interact with operational needs. Analytical sensitivity describes the lowest detectable target concentration. Clinical sensitivity expresses the proportion of true positives correctly detected. For antigen kits this is generally lower than for RT-PCR, especially early or late in infection when viral load is low. Specificity expresses the proportion of true negatives correctly identified. High specificity limits false alarms that would interrupt crew rotations or port calls. Turnaround time separates the two platforms most starkly. Rapid antigen results appear within minutes at the point of care. RT-PCR requires extraction, amplification, and qualified interpretation, so turnaround runs from hours on equipped vessels to longer periods when samples go ashore. Maritime programmes should document the claimed performance of each adopted kit, record lot numbers, and confirm onboard operators have completed competency training. When a result will drive isolation or diversion decisions, weigh the risk of a false negative against the cost of waiting for a confirmatory molecular result.

Onboard

testing protocols and outbreak response criteria
A written protocol converts testing capability into repeatable decision-making. The document should specify routine screening frequency for crew and pre-embarkation requirements for joining personnel. It should also set testing triggers such as fever or respiratory symptoms, and the chain of custody for specimens sent to shore laboratories. Outbreak response criteria normally activate when a defined number of linked cases occurs within a set period. The protocol then prescribes isolation of cases in designated cabins, quarantine of close contacts, mask and distancing measures, enhanced cleaning with disinfectants, and expanded testing of all persons aboard regardless of symptoms. Environmental sampling should follow each disinfection cycle until consecutive negative results are obtained. The protocol must also assign responsibility for reporting to port health authorities and for record retention. Records cover specimen logs, assay lot details, operator identity, and result interpretation. Post-event review of testing records against the outbreak timeline shows where screening intervals or coverage should be tightened for future voyages.